Drug Shortages in Germany - A Critical Assessment.

Dr Ralf Hess, Dominik M. Aumer, Moritz Haucke and Dr Simon Schulz publish articles on drug shortages and their causes in RAPS.

Together with the two Managing Partners of Entourage, Dominik M. Aumer and Moritz Haucke, our Management Consultants Dr Ralf Hess and Dr Simon Schulz have published an article on the drug shortage and its causes in the Regulatory Affairs Professionals Society.

From the perspective of a medium-sized generic drug manufacturer, the article analyses the causes of the drug shortage in Germany and the causes of production problems at active ingredient and drug manufacturers. Measures to limit damage in a "broken marketplace" are discussed and in the epilogue, the current COVID 19 pandemic is discussed and a warning is given that medicines and active ingredients from China and India could become scarce due to the disruptions caused by the pandemic.

At the following link you can find the article.

Read here.

Share Article.

Facebook
Twitter
LinkedIn
XING
WhatsApp
Email

Persons to the article.

Moritz Haucke

Founder & Managing Partner

Moritz Haucke, M.A. is the founder and Managing Partner of Entourage GmbH. He studied Information Science, Business Administration and Philosophy at Saarland University and looks back on many years of experience in HR consulting.
For a leading Anglo-Saxon recruitment company, Mr. Haucke successfully built up new markets in German-speaking countries and was subsequently responsible for the pharmaceutical sector for the D/A/CH region. Accordingly, he has excellent knowledge of GxP-regulated markets and an excellent network of experts and decision-makers within the pharmaceutical industry.
Moritz Haucke is Managing Director of Entourage GmbH and member of the Board of Directors of Entourage Pharma Consulting AG.

Dominik M. Aumer

Founder & Managing Partner

Dipl.-Kfm. Dominik M. Aumer is an independent management consultant and founder of Entourage GmbH. He studied business administration at Saarland University and looks back on more than ten years of experience in strategic consulting and human resources development.
Mr. Aumer has deep knowledge in sales-related personnel and organisational development and an excellent network to decision makers and experts in the service industry. With the process-based method of Sales Process Consultancy that he developed, he designed scientifically sound concepts for sales personnel development as a consultant to sales organisations. In 2013 he was also voted one of the Top 100 Trainers Excellent in Germany.
Dominik M. Aumer is Managing Director of Entourage GmbH and a member of the Board of Directors of Entourage Pharma Consulting AG.

Dr Ralf Hess

Principal Consultant IVD

Dr. Ralf Hess studied biology at the Albert-Ludwigs-University of Freiburg, where he also completed his doctorate at the Institute of Virology. Dr. Hess has many years of experience in the development of medical devices and medicinal products and their combination, in laboratory analysis and quality assurance. The quality expert has set up, implemented and maintained QM systems in accordance with ISO and GxP for various areas of application. The customer service portfolio ranges from manufacturers of classical and biological drugs, medical device companies and vaccine manufacturers to immunohistochemical, immunological, molecular biological and serological diagnostic laboratories. Dr. Hess works worldwide as an auditor in the GxP/ISO area and has many years of experience in FDA remediation projects and the regulatory development of combination products (drug device products).
Dr. Ralf Hess supports Entourage as Principal Consultant IVD.

Assoc. Prof. Dr Simon Schulz

Senior Management Consultant

Assoc. Prof. Dr. Simon Schulz received his diploma in chemistry from the Ruprecht Karls University of Heidelberg. He received his doctorate from the Institute of Physical and Biophysical Chemistry; Heidelberg, and the Max-Planck Institute for Intelligent Systems, Stuttgart. In 2016, he was appointed Associate Professor in Experimental Medicine by the University Medical Centre Freiburg.
Dr. Schulz has many years of experience in GLP compliance and computer validation as well as the development and testing of medical devices and combination products. He has extensive expertise in the compliance of medical devices with ISO 13485 and FDA 483 according to 21 CFR 820 and the development of compliant SOPs for their design and manufacturing process. Furthermore, he has distinct competence in CAPA management, complaint handling and process validation. He is lecturer for quality of medical devices and medicinal products at the University Freiburg, Faculty for Chemistry & Pharmacy.
Dr. Simon Schulz supports Entourage as Senior Management Consultant.

Newsletter.

Read more.

COVID-19 vaccine roll-out becomes largest in supply chain history.
The introduction of the COVID-19 vaccine is becoming the biggest challenge ...
How the Next Generation Supply Chain is emerging.
The next generation supply chain needs not only digital ...
News on the harmonized standard ISO 15223.
News on the harmonized standard ISO 15223.
The future of the pharmaceutical industry is data-driven operations.
Data-driven surgery is the trend of the future in ...
MDR postponed. By EU. Because of Corona.
Due to the SARS-CoV-2 pandemic, the EU has proposed to extend the ...